Dey R, Nayak S, Das P, Yadav S. Short Synthesis of Molnupiravir (EIDD-2801)
via a Thionated Uridine Intermediate.
ACS OMEGA 2021;
6:28366-28372. [PMID:
34723033 PMCID:
PMC8552467 DOI:
10.1021/acsomega.1c04550]
[Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/20/2021] [Accepted: 09/23/2021] [Indexed: 05/04/2023]
Abstract
Molnupiravir (MK-4482, EIDD-2801) is an experimental drug that has been demonstrated to be effective for the treatment of COVID-19 in human clinical trials. Herein, we report a concise synthesis of the drug via a novel thionated derivative that relies on one-pot methodologies, thus decreasing the number of purification steps required. This route provides the drug in an overall 62% yield and >99% purity and uses cheap and readily available bulk chemicals, thereby providing an affordable synthesis of the drug for cheaper and wider global accessibility.
Collapse